Immune Therapeutics, Inc. (IMUN) Stock Analysis
DELISTED
What happened to Immune Therapeutics, Inc. (IMUN) stock?
Immune Therapeutics, Inc. (IMUN) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $7.78M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Immune Therapeutics, Inc. (IMUN). Immune Therapeutics, Inc. is a healthcare company that currently does not have significant operations. Formerly known as TNI BioTech, Inc., the company changed its name in October 2014 and is headquartered in Orlando, Florida.
Last analyzed: Mar 16, 2026Immune Therapeutics, Inc. (IMUN) Healthcare & Pipeline Overview
IMUN OTC Market Information
IMUN trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy IMUN shares?
No. IMUN stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for IMUN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before IMUN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Immune Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.